A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma

NCT03687034 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolomide
DEVICE: Optune

Sponsor

Leaf Vertical Inc.